Romain Desert

Romain Desert

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

The extracellular matrix in cancer-associated fibrosis: molecular mechanisms and clinical relevance.

The extracellular matrix in cancer-associated fibrosis: molecular mechanisms and clinical relevance.

Journal: JCI insight
Published: July 08, 2026

Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

Journal: Science translational medicine
Published: June 03, 2026

Renewed momentum for HCV and HCC research.

Renewed momentum for HCV and HCC research.

Journal: Journal of hepatology
Published: March 20, 2026

Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models.

Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models.

Journal: Gut and liver
Published: July 08, 2025

Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment.

Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment.

Journal: Gut
Published: October 29, 2024

Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.

Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.

Journal: Journal of hepatology
Published: September 13, 2024

Intestinal Epithelial Cell-derived Osteopontin Protects Against Metabolic Dysfunction-associated Steatohepatitis by Modulating Bile Acid Composition and the Gut Microbiome.

Intestinal Epithelial Cell-derived Osteopontin Protects Against Metabolic Dysfunction-associated Steatohepatitis by Modulating Bile Acid Composition and the Gut Microbiome.

Journal: Cellular and molecular gastroenterology and hepatology
Published: August 27, 2024

Post-translational modifications drive the effects of HMGB1 in alcohol-associated liver disease.

Post-translational modifications drive the effects of HMGB1 in alcohol-associated liver disease.

Journal: Hepatology communications
Published: July 12, 2024

A Protein Complex of Liver Origin Activates a Pro-inflammatory Program That Drives Hepatic and Intestinal Injury in Alcohol-Associated Liver Disease.

A Protein Complex of Liver Origin Activates a Pro-inflammatory Program That Drives Hepatic and Intestinal Injury in Alcohol-Associated Liver Disease.

Journal: Cellular and molecular gastroenterology and hepatology
Published: January 03, 2024

Reply: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?

Reply: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?

Journal: Hepatology (Baltimore, Md.)
Published: December 13, 2023

Ablation of secreted phosphoprotein-1 in hepatocytes increases fatty acid oxidation and ameliorates alcohol-associated liver disease.

Ablation of secreted phosphoprotein-1 in hepatocytes increases fatty acid oxidation and ameliorates alcohol-associated liver disease.

Journal: Alcohol, clinical & experimental research
Published: October 04, 2023

Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in mice.

Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in mice.

Journal: Journal of hepatology
Published: May 31, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026